BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20134017)

  • 1. Transmission potential of two chimeric western equine encephalitis vaccine candidates in Culex tarsalis.
    Kenney JL; Adams AP; Weaver SC
    Am J Trop Med Hyg; 2010 Feb; 82(2):354-9. PubMed ID: 20134017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus.
    Atasheva S; Wang E; Adams AP; Plante KS; Ni S; Taylor K; Miller ME; Frolov I; Weaver SC
    Vaccine; 2009 Jul; 27(32):4309-19. PubMed ID: 19446595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of salivary gland escape barriers to western equine encephalitis virus in the natural vector, Culex tarsalis.
    Stauft CB; Phillips AT; Wang TT; Olson KE
    PLoS One; 2022; 17(3):e0262967. PubMed ID: 35298486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates.
    Turell MJ; O'Guinn ML; Parker MD
    Am J Trop Med Hyg; 2003 Feb; 68(2):218-21. PubMed ID: 12641414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of mouse neurovirulence and mosquito infection for Western equine encephalitis virus.
    Mossel EC; Ledermann JP; Phillips AT; Borland EM; Powers AM; Olson KE
    PLoS One; 2013; 8(3):e60427. PubMed ID: 23544138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Culex Tarsalis Mosquitoes as Vectors of Highlands J Virus.
    Borland EM; Ledermann JP; Powers AM
    Vector Borne Zoonotic Dis; 2016 Aug; 16(8):558-65. PubMed ID: 27248005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary genetics and vector adaptation of recombinant viruses of the western equine encephalitis antigenic complex provides new insights into alphavirus diversity and host switching.
    Allison AB; Stallknecht DE; Holmes EC
    Virology; 2015 Jan; 474():154-62. PubMed ID: 25463613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
    Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
    Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chimeric Sindbis-based vaccine protects cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus.
    Roy CJ; Adams AP; Wang E; Leal G; Seymour RL; Sivasubramani SK; Mega W; Frolov I; Didier PJ; Weaver SC
    Vaccine; 2013 Mar; 31(11):1464-70. PubMed ID: 23333212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Erasmus JH; Seymour RL; Kaelber JT; Kim DY; Leal G; Sherman MB; Frolov I; Chiu W; Weaver SC; Nasar F
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental infection of Aedes sollicitans and Aedes taeniorhynchus with two chimeric Sindbis/Eastern equine encephalitis virus vaccine candidates.
    Arrigo NC; Watts DM; Frolov I; Weaver SC
    Am J Trop Med Hyg; 2008 Jan; 78(1):93-7. PubMed ID: 18187790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.
    Reed DS; Glass PJ; Bakken RR; Barth JF; Lind CM; da Silva L; Hart MK; Rayner J; Alterson K; Custer M; Dudek J; Owens G; Kamrud KI; Parker MD; Smith J
    J Virol; 2014 Oct; 88(20):12077-86. PubMed ID: 25122801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
    Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
    Front Immunol; 2020; 11():598847. PubMed ID: 33542715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of time after infection, mosquito genotype, and infectious viral dose on the dynamics of Culex tarsalis vector competence for western equine encephalomyelitis virus.
    Mahmood F; Chiles RE; Fang Y; Green EN; Reisen WK
    J Am Mosq Control Assoc; 2006 Jun; 22(2):272-81. PubMed ID: 17019773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses.
    Phillips AT; Schountz T; Toth AM; Rico AB; Jarvis DL; Powers AM; Olson KE
    J Virol; 2014 Feb; 88(3):1771-80. PubMed ID: 24257615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory studies on the transmission of western equine encephalitis virus by Saskatchewan mosquitoes. I. Culex tarsalis.
    Hayles LB; McLintock J; Saunders JR
    Can J Comp Med; 1972 Apr; 36(2):83-8. PubMed ID: 4259935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vector competence of Culex tarsalis (Diptera: Culicidae) from Iowa for a sympatric strain of western equine encephalomyelitis (WEE-7738) virus.
    Lee JH; Rowley WA; Platt KB
    J Med Entomol; 2000 Jan; 37(1):194-7. PubMed ID: 15218927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the recombinant alphavirus Western equine encephalitis virus revealed by cryoelectron microscopy.
    Sherman MB; Weaver SC
    J Virol; 2010 Oct; 84(19):9775-82. PubMed ID: 20631130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for studying the vector competence of Culex tarsalis for western equine encephalomyelitis virus.
    Mahmood F; Chiles RE; Fang Y; Reisen WK
    J Am Mosq Control Assoc; 2004 Sep; 20(3):277-82. PubMed ID: 15532927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine.
    Wu JQ; Barabé ND; Chau D; Wong C; Rayner GR; Hu WG; Nagata LP
    Vaccine; 2007 May; 25(22):4368-75. PubMed ID: 17467858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.